Skip to main content
Syncona Limited logo

Syncona Limited — Investor Relations & Filings

Ticker · SYNC ISIN · GG00B8P59C08 LEI · 213800X8MBI5VQITLW60 IL Financial and insurance activities
Open in API
Filings indexed 1,030 across all filing types
Latest filing 2024-03-21 Transaction in Own Shar…
Country GG Guernsey
Listing IL SYNC

About Syncona Limited

https://www.synconaltd.com/

Syncona Limited is a life science investment company focused on founding, building, and funding a portfolio of healthcare businesses. The company's strategy is to identify and advance exceptional science to create globally leading companies capable of delivering transformational treatments to patients, particularly in areas with high unmet medical needs. Its portfolio is concentrated in innovative therapeutic areas, including gene therapy, cell therapy, and biologics. Syncona actively manages its companies to reach key value inflection points, aiming to generate significant long-term capital appreciation for shareholders through strategic events such as mergers, acquisitions, and other liquidity events.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document explicitly states 'Transaction in Own Shares' in the title section. It details the purchase of 140,000 ordinary shares by the company as part of a 'share buyback programme'. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS), which covers company buying back or selling its own shares (share repurchase/issuance). The presence of the RNS Number and the LSE footer confirms it is a regulatory announcement, but the specific content dictates the POS classification over the general RNS.
2024-03-21 English
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document explicitly announces a 'Transaction in Own Shares' detailing the purchase of 50,000 ordinary shares as part of a share buyback programme. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). The presence of the RNS Number and the closing statement referencing RNS confirms it is a regulatory announcement, but the specific content dictates the POS classification over the general RNS fallback.
2024-03-20 English
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document explicitly states the subject is 'Transaction in Own Shares' and details the purchase of ordinary shares by the company (Syncona Limited) as part of a 'share buyback programme'. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). The presence of the RNS Number and the closing statement referencing RNS confirms it is a regulatory announcement, but the specific content dictates the POS classification over the general RNS fallback.
2024-03-19 English
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document explicitly states the subject is 'Transaction in Own Shares' and details the purchase of 100,000 ordinary shares by the company as part of a 'share buyback programme'. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). The presence of the RNS Number and the closing statement confirming the information is provided by RNS (the news service of the London Stock Exchange) confirms it is a regulatory announcement, but the specific content dictates the POS classification over the general RNS fallback.
2024-03-18 English
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document explicitly announces a 'Transaction in Own Shares' (share buyback program execution) detailing the number of shares purchased, the price, and the resulting treasury share count. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). The presence of the RNS Number and the closing statement confirming the information is provided by RNS (London Stock Exchange's news service) confirms it is a regulatory announcement, but the specific content dictates the POS classification over the general RNS fallback.
2024-03-15 English
Autolus reports full year 2023 Financial Results
Earnings Release Classification · 1% confidence The document is an announcement by Syncona Limited noting that its portfolio company, Autolus Therapeutics plc, has reported its 'full year 2023 Financial Results and business updates'. The text contains key financial highlights (cash position, operating expenses, R&D spend) and operational updates (regulatory submissions, collaborations, management changes) for the full year ended December 31, 2023. This structure—a summary of annual financial performance and business activities released by the company—is characteristic of an Earnings Release (ER) or a summary preceding a full Annual Report (10-K). Since the document explicitly states it is announcing 'Financial Results' and provides key figures, but is distributed via RNS (RNS Number : 8808G) and is likely a press release summarizing the full results (which would be in the 10-K), the most appropriate classification is Earnings Release (ER). It is not the full 10-K, nor is it just a proxy statement (DEF 14A) or a management discussion (MDA), as it contains the core financial figures. FY 2023
2024-03-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.